Beginning Cash: The amount of cash reported by the company on its previous statement.
Heron Therapeutics, Inc. (HRTX) had Beginning Cash of $25.80M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$38.90M |
|
$2.63M |
|
$8.46M |
|
$30.45M |
|
$35.75M |
|
$3.15M |
|
$-0.52M |
|
$2.63M |
|
$2.63M |
|
$2.63M |
|
$2.63M |
|
$2.63M |
|
$2.63M |
|
$3.15M |
|
$3.63M |
|
153.49M |
|
196.92M |
|
$0.02 |
|
$0.01 |
|
| Balance Sheet Financials | |
$212.84M |
|
$14.54M |
|
$22.91M |
|
$235.75M |
|
$88.56M |
|
$174.97M |
|
$175.65M |
|
$264.20M |
|
$-28.45M |
|
$-28.45M |
|
$-28.45M |
|
152.43M |
|
| Cash Flow Statement Financials | |
$-8.87M |
|
$2.27M |
|
$0.06M |
|
|
Beginning Cash |
$25.80M |
$19.27M |
|
$-6.53M |
|
$2.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
1.19 |
|
-6.15 |
|
78.26% |
|
8.11% |
|
8.11% |
|
-- |
|
6.77% |
|
6.77% |
|
$-8.94M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.15 |
|
0.49 |
|
182.15 |
|
-9.26% |
|
-9.26% |
|
1.12% |
|
1.80% |
|
$-0.19 |
|
$-0.05 |
|
$-0.04 |
|